These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3595648)

  • 1. Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.
    van Aalderen WM; Knoester H; Knol K
    Eur J Pediatr; 1987 May; 146(3):290-1. PubMed ID: 3595648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
    Girling DJ
    Tubercle; 1978 Mar; 59(1):13-32. PubMed ID: 345572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma.
    Dietrich CG; Gartung C; Lorenzen J; Geier A; Wasmuth HE; Matern S; Lammert F
    Ann Hepatol; 2004; 3(3):118-20. PubMed ID: 15505599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
    Fiala W; Häcki MA; Brändli O
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1956-9. PubMed ID: 6658432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
    Mukerjee CM; McKenzie DK
    Aust N Z J Med; 1985 Apr; 15(2):226-9. PubMed ID: 3861165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
    Jasmer RM; Saukkonen JJ; Blumberg HM; Daley CL; Bernardo J; Vittinghoff E; King MD; Kawamura LM; Hopewell PC;
    Ann Intern Med; 2002 Oct; 137(8):640-7. PubMed ID: 12379063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 12. [Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
    Göpel B; Götte K
    Laryngorhinootologie; 2005 Aug; 84(8):610-9; quiz 621-2. PubMed ID: 16080064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic dysfunction in undernourished patients receiving isoniazid and rifampicin.
    Krishnaswamy K; Prasad CE; Murthy KJ
    Trop Geogr Med; 1991; 43(1-2):156-60. PubMed ID: 1750106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of pyrazinamide: cohort and case-control analyses.
    Chang KC; Leung CC; Yew WW; Lau TY; Tam CM
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1391-6. PubMed ID: 18388355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
    Costin M; Tesloianu A; Mihăescu T; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1988 Apr; 30(763):43-4. PubMed ID: 3352531
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.